Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Fagan

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 1, 1997
Regional cerebral hemodynamics among hypertensive patients in subacute and chronic phasesS C Fagan
DICP : the Annals of Pharmacotherapy|March 1, 1991
Nimodipine and bradycardia in acute stroke--drug or disease?S C Fagan, N Nacci
Expert Opinion on Pharmacotherapy|May 5, 2001
Pharmacology and clinical experience with simvastatinD C Hess, S C Fagan
Pharmacotherapy|February 25, 1999
Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activatorS C Fagan, J H Garcia
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 23, 1997
Thrombolysis in acute ischemic strokeP Dumo, S C Fagan, J Carhuapoma
The Annals of Pharmacotherapy|January 1, 1992
"Brain attack": an indication for thrombolysis?S C Fagan, B J Zarowitz, S Robert
Pharmacotherapy|January 1, 1991
Ticlopidine: a new antiplatelet agent for cerebrovascular diseaseS Robert, A J Miller, S C Fagan
Clinical and Experimental Pharmacology & Physiology|August 1, 1986
Prostanoid concentrations in human CSF following acute ischaemic brain infarctionS C Fagan, D Castellani, F M Gengo
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007
Editorial commentaryS C Fagan, J David Spence, P Mitsias
The Annals of Pharmacotherapy|April 1, 1994
Safety of combination aspirin and anticoagulation in acute ischemic strokeS C Fagan, H R Kertland, G E Tietjen
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 1, 1997
Regional cerebral hemodynamics among hypertensive patients in subacute and chronic phasesS C Fagan
DICP : the Annals of Pharmacotherapy|March 1, 1991
Nimodipine and bradycardia in acute stroke--drug or disease?S C Fagan, N Nacci
Expert Opinion on Pharmacotherapy|May 5, 2001
Pharmacology and clinical experience with simvastatinD C Hess, S C Fagan
Pharmacotherapy|February 25, 1999
Hemorrhagic transformation in focal cerebral ischemia: influence of time to artery reopening and tissue plasminogen activatorS C Fagan, J H Garcia
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 23, 1997
Thrombolysis in acute ischemic strokeP Dumo, S C Fagan, J Carhuapoma
The Annals of Pharmacotherapy|January 1, 1992
"Brain attack": an indication for thrombolysis?S C Fagan, B J Zarowitz, S Robert
Pharmacotherapy|January 1, 1991
Ticlopidine: a new antiplatelet agent for cerebrovascular diseaseS Robert, A J Miller, S C Fagan
Clinical and Experimental Pharmacology & Physiology|August 1, 1986
Prostanoid concentrations in human CSF following acute ischaemic brain infarctionS C Fagan, D Castellani, F M Gengo
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007
Editorial commentaryS C Fagan, J David Spence, P Mitsias
The Annals of Pharmacotherapy|April 1, 1994
Safety of combination aspirin and anticoagulation in acute ischemic strokeS C Fagan, H R Kertland, G E Tietjen
Pageof 5